Table 1 HDAC1, HDAC4 and HDAC6 inhibition assay of K-178, K-178SH, K-181, K-181SH, Tubacin and Trichostatin A.

From: MDMX elevation by a novel Mdmx–p53 interaction inhibitor mitigates neuronal damage after ischemic stroke

Compound tested

HDAC1 activity assay

HDAC4 activity assay

HDAC6 activity assay

Inhibition (%)

Average of Inhibition (%)

Inhibitory activity*

Inhibition (%)

Average of Inhibition (%)

Inhibitory activity*

Inhibition (%)

Average of Inhibition (%)

Inhibitory activity*

K-178

17.75

7.93

12.84

N/A

13.19

6.95

10.07

N/A

39.74

30.59

35.16

N/A

K-178SH

5.56

12.23

8.9

N/A

9.89

8.1

8.99

N/A

41.16

35.49

38.32

N/A

K-181

16.76

17.1

16.93

N/A

12.22

12.22

12.22

N/A

55.51

59.12

57.32

Yes

K-181SH

21.58

24.73

23.15

N/A

14.38

16.3

15.34

N/A

68.85

70.78

69.81

Yes

Tubacin

97.65

97.22

97.43

Yes

87.71

87.27

87.49

Yes

100

100

100

Yes

Trichostatin A

99.94

99.61

99.78

Yes

97.7

97.51

97.61

Yes

99.37

99.54

99.45

Yes

  1. *HDAC inhibitory effect is defined as “Average of Inhibition (%)” > 50.